Search Results
DDx Strength: Weak
atezolizumab, Rash or multiple lesions, 50-59 year old Female

Edit Findings
Exanthematous drug eruptionExanthematous drug eruption
Bacterial sepsisBacterial sepsis
Drug-induced hepatotoxicity
Pruritus without rashPruritus without rash
Bullous drug eruption
Eosinophilic fasciitisEosinophilic fasciitis
PsoriasisPsoriasis
Alopecia areataAlopecia areata
Lichenoid drug eruptionLichenoid drug eruption
Stevens-Johnson syndromeStevens-Johnson syndrome
Hemophagocytic lymphohistiocytosisHemophagocytic lymphohistiocytosis
VitiligoVitiligo
Fixed drug eruptionFixed drug eruption
Acute generalized exanthematous pustulosisAcute generalized exanthematous pustulosis
Bullous pemphigoidBullous pemphigoid
Linear IgA bullous dermatosisLinear IgA bullous dermatosis
Drug-induced sclerodermoid reactions
Cutaneous adverse effects of immune checkpoint inhibitors
DehydrationDehydration
Drug-induced abdominal pain
Drug-induced cough
Drug-induced diarrhea
Drug-induced nausea or vomiting
HypothyroidismHypothyroidism
Immune checkpoint inhibitor-related adverse effects
Insomnia
Urinary tract infection
Acute kidney injury
Colitis
Delirium
Diabetic ketoacidosis
Drug-induced anorexia
Drug-induced arthralgia
Drug-induced constipation
Drug-induced dyspnea
Drug-induced fatigue
Drug-induced fever
Drug-induced headache
Drug-induced hematuria
Drug-induced myopathies
Halo nevusHalo nevus
Hyperthyroidism
Hyponatremia
Ocular drug reaction
Peripheral neuropathy
Pleural effusionPleural effusion
Pulmonary embolismPulmonary embolism
Drug-induced diabetes
Drug-induced weakness
Myocarditis
Rhabdomyolysis
UveitisUveitis
Myasthenia gravis
Peripheral ulcerative keratitis
Hemolytic anemia
Drug-induced anemia
Cardiogenic shock